STOCK TITAN

[Form 4] ARGAN INC Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Argan, Inc. (AGX) reported insider activity by an officer on 10/15/2025. The reporting person exercised stock options to acquire 5,235 shares at $42.31 and 4,765 shares at $33.81, then conducted an open‑market sale of 10,000 shares at an average price of $309.37.

Following these transactions, the filer reported 21,006 shares of common stock held directly. The reporting person is identified as Chief Executive Officer, Gemma.

Argan, Inc. (AGX) ha riportato attività interne da parte di un dirigente il 15/10/2025. La persona che presenta il rapporto ha esercitato opzioni su azioni per acquisire 5.235 azioni a 42,31$ e 4.765 azioni a 33,81$, poi ha effettuato una vendita sul mercato aperto di 10.000 azioni a un prezzo medio di 309,37$.

A seguito di tali operazioni, il dichiarante ha riferito 21.006 azioni di azioni ordinarie detenute direttamente. Il dichiarante è identificato come Amministratore Delegato, Gemma.

Argan, Inc. (AGX) informó actividad de insider por parte de un directivo el 15/10/2025. La persona que reporta ejerció opciones sobre acciones para adquirir 5.235 acciones a 42,31$ y 4.765 acciones a 33,81$, y luego realizó una venta en el mercado abierto de 10.000 acciones a un precio promedio de 309,37$.

Después de estas transacciones, el presentante reportó 21.006 acciones de acciones ordinarias en posesión directa. La persona reportante se identifica como Director Ejecutivo, Gemma.

Argan, Inc. (AGX) 는 임원에 의한 내부자 거래를 2025년 10월 15일에 보고했습니다. 보고자는 42.31달러에 5,235주33.81달러에 4,765주의 주식 옵션을 행사한 다음 평균가 309.37달러에 10,000주를 시장가로 매도했습니다.

이러한 거래 후 신고인은 직접 보유한 21,006주의 일반주를 보유하고 있다고 보고했습니다. 보고자는 Gemma의 최고경영자로 식별됩니다.

Argan, Inc. (AGX) a signalé une activité d’initié par un dirigeant le 15/10/2025. La personne faisant le rapport a exercé des options pour acquérir 5 235 actions à 42,31$ et 4 765 actions à 33,81$, puis a procédé à une vente sur le marché libre de 10 000 actions à un prix moyen de 309,37$.

Suite à ces transactions, le déclarant détient 21 006 actions d’actions ordinaires détenues directement. Le déclarant est identifié comme Chef de la direction, Gemma.

Argan, Inc. (AGX) meldete Insider-Tätigkeiten eines Offiziers am 15.10.2025. Die meldende Person hat Aktienoptionen ausgeübt, um 5.235 Aktien zu 42,31$ zu erwerben, und 4.765 Aktien zu 33,81$, gefolgt von einem offenen Verkauf von 10.000 Aktien zu einem Durchschnittspreis von 309,37$.

Nach diesen Transaktionen meldete der Anmelder 21.006 Aktien Stammaktien, direkt gehalten. Die meldende Person wird als Chief Executive Officer, Gemma identifiziert.

Argan, Inc. (AGX) أبلغت عن نشاط داخلي من قِبل موظف/تنفيذي في 15/10/2025. قام صاحب البلاغ بممارسة خيارات أسهم لشراء 5,235 سهماً بسعر 42.31 دولاراً و 4,765 سهماً بسعر 33.81 دولاراً, ثم أجرى بيعاً في السوق المفتوح لـ 10,000 سهم بسعر متوسط 309.37 دولاراً.

بعد هذه المعاملات، أبلغ المُبلغ عن 21,006 سهماً من الأسهم العادية المحتفظ بها مباشرة. يُعرّف المُبلغ نفسه بــ المدير التنفيذي، Gemma.

Argan, Inc. (AGX) 报告了一名高管在 2025/10/15 的内部人交易。该报告人行使股票期权,取得了 5,235 股,价格 42.31 美元,以及 4,765 股,价格 33.81 美元,随后在公开市场以 平均价格 309.37 美元/股 出售了 10,000 股

在这些交易之后,披露者直接持有 21,006 股普通股。披露人被识别为 Gemma 的首席执行官

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Argan, Inc. (AGX) ha riportato attività interne da parte di un dirigente il 15/10/2025. La persona che presenta il rapporto ha esercitato opzioni su azioni per acquisire 5.235 azioni a 42,31$ e 4.765 azioni a 33,81$, poi ha effettuato una vendita sul mercato aperto di 10.000 azioni a un prezzo medio di 309,37$.

A seguito di tali operazioni, il dichiarante ha riferito 21.006 azioni di azioni ordinarie detenute direttamente. Il dichiarante è identificato come Amministratore Delegato, Gemma.

Argan, Inc. (AGX) informó actividad de insider por parte de un directivo el 15/10/2025. La persona que reporta ejerció opciones sobre acciones para adquirir 5.235 acciones a 42,31$ y 4.765 acciones a 33,81$, y luego realizó una venta en el mercado abierto de 10.000 acciones a un precio promedio de 309,37$.

Después de estas transacciones, el presentante reportó 21.006 acciones de acciones ordinarias en posesión directa. La persona reportante se identifica como Director Ejecutivo, Gemma.

Argan, Inc. (AGX) 는 임원에 의한 내부자 거래를 2025년 10월 15일에 보고했습니다. 보고자는 42.31달러에 5,235주33.81달러에 4,765주의 주식 옵션을 행사한 다음 평균가 309.37달러에 10,000주를 시장가로 매도했습니다.

이러한 거래 후 신고인은 직접 보유한 21,006주의 일반주를 보유하고 있다고 보고했습니다. 보고자는 Gemma의 최고경영자로 식별됩니다.

Argan, Inc. (AGX) a signalé une activité d’initié par un dirigeant le 15/10/2025. La personne faisant le rapport a exercé des options pour acquérir 5 235 actions à 42,31$ et 4 765 actions à 33,81$, puis a procédé à une vente sur le marché libre de 10 000 actions à un prix moyen de 309,37$.

Suite à ces transactions, le déclarant détient 21 006 actions d’actions ordinaires détenues directement. Le déclarant est identifié comme Chef de la direction, Gemma.

Argan, Inc. (AGX) meldete Insider-Tätigkeiten eines Offiziers am 15.10.2025. Die meldende Person hat Aktienoptionen ausgeübt, um 5.235 Aktien zu 42,31$ zu erwerben, und 4.765 Aktien zu 33,81$, gefolgt von einem offenen Verkauf von 10.000 Aktien zu einem Durchschnittspreis von 309,37$.

Nach diesen Transaktionen meldete der Anmelder 21.006 Aktien Stammaktien, direkt gehalten. Die meldende Person wird als Chief Executive Officer, Gemma identifiziert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Collins Charles Edwin IV

(Last) (First) (Middle)
C/O ARGAN, INC.
4075 WILSON BLVD, SUITE 440

(Street)
ARLINGTON VA 22203

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF EXECUTIVE OFFICER, GEMMA
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/15/2025 M 5,235(1) A $42.31 26,241 D
Common Stock 10/15/2025 M 4,765(2) A $33.81 31,006 D
Common Stock 10/15/2025 S 10,000(3) D $309.37 21,006 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Stock $42.31 10/15/2025 M 5,235(1) 09/10/2020 09/10/2029 Common Stock 5,235 $42.31 19,500 D
Option to Purchase Common Stock $33.81 10/15/2025 M 4,765(2) 04/16/2021 04/16/2030 Common Stock 4,765 $33.81 14,735 D
Explanation of Responses:
1. On October 15, 2025, the Reporting Person exercised the remaining portion of his stock option awarded on September 10, 2019 to purchase 5,235 shares of the Issuer's common stock at a price of $42.31 per share.
2. On October 15, 2025, the Reporting Person exercised a portion of his stock option awarded on April 16, 2020 to purchase 4,765 shares of the Issuer's common stock at a price of $33.81 per share.
3. On October 15, 2025, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at an average price of $309.37 per share.
/s/ Charles E. Collins IV 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AGX disclose?

The officer exercised options for 5,235 shares at $42.31 and 4,765 shares at $33.81, and sold 10,000 shares at $309.37 on 10/15/2025.

How many AGX shares were sold and at what price?

The filer sold 10,000 shares at an average price of $309.37.

What is the insider’s remaining AGX share ownership?

After the transactions, the filer reported 21,006 shares held directly.

What roles does the reporting person hold at AGX?

The reporting person is an Officer, serving as Chief Executive Officer, Gemma.

When did the AGX insider transactions occur?

All reported transactions occurred on 10/15/2025.

What types of securities were involved?

Common stock acquired via option exercises and common stock sold in the open market, as reported in Form 4 Tables I and II.
Argan Inc

NYSE:AGX

AGX Rankings

AGX Latest News

AGX Latest SEC Filings

AGX Stock Data

4.09B
13.30M
4.48%
89.2%
5.37%
Engineering & Construction
Construction - Special Trade Contractors
Link
United States
ARLINGTON